| |
Internal set
|
External set
|
|---|
|
Total number of patients
|
170
|
108
|
|
Grading
|
|
1
|
12 (7%)
|
17 (16%)
|
|
2
|
76 (45%)
|
55 (51%)
|
|
3
|
82 (48%)
|
26 (24%)
|
|
unknown
|
0 (0%)
|
10 (9%)
|
|
Node
|
|
Negative
|
67 (39%)
|
55 (51%)
|
|
Positive
|
77 (46%)
|
38 (35%)
|
|
unknown
|
26 (15%)
|
15 (14%)
|
|
HR Status
|
|
ER and/or PgR positive
|
132 (78%)
|
99 (92%)
|
|
ER /PgR negative
|
38 (22%)
|
9 (8%)
|
|
Ki67
|
|
High ≥20%
|
97 (57%)
|
52 (48%)
|
|
Low < 20%
|
73 (43%)
|
56 (52%)
|
|
HER2 gene s/n
|
|
<4.0
|
61a (36%)
|
80b(74%)
|
|
4.0–5.9
|
54a(32%)
|
10b (9%)
|
|
≥6.0
|
55a (32%)
|
18b(17%)
|
-
HR Hormonal Receptor, ER Estrogen Receptor,PgR Progesterone Receptor, s/n signals/nucleus
-
aSilver In Situ Hybridization; bFluorescence In Situ Hybridization
